Medications

70 bookmarks
Custom sorting
The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia
The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia
Cognitive impairment is a core symptom of schizophrenia and a major determinant of poor long-term functional outcomes. Despite considerable efforts, we do not yet have any approved pharmacological treatments for cognitive impairment associated with ...
The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia
Dementia with Lewy bodies - Wikipedia
Dementia with Lewy bodies - Wikipedia
Dementia with Lewy bodies (DLB) is a type of dementia characterized by changes in sleep, behavior, cognition, movement, and regulation of automatic bodily functions. Memory loss is not always an early symptom. The disease worsens over time and is usually diagnosed when cognitive impairment interferes with normal daily functioning. Together with Parkinson's disease dementia, DLB is one of the two Lewy body dementias. It is a common form of dementia, but the prevalence is not known accurately and many diagnoses are missed. The disease was first described on autopsy by Kenji Kosaka in 1976, and he named the condition several years later.
Dementia with Lewy bodies - Wikipedia
Aripiprazole Side Effects: Common, Severe, Long Term
Aripiprazole Side Effects: Common, Severe, Long Term
Learn about the side effects of aripiprazole, from common to rare, for consumers and healthcare professionals.
jerking, or stiffness
restlessness
shuffling walk
stiffness of the limbs
difficulty with speaking drooling loss of balance control
loss of bladder control
Aripiprazole Side Effects: Common, Severe, Long Term
Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infection
Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infection
"patients in treatment of RCDI and regularly encountered post-FMT re-infections with C. difficile following uncomplicated UTI treatment with all commonly used oral antibiotics, including quinolones, penicillins, cephalosporins, macrolides, sulfamethoxazole/trimethoprim, nitrofurantoin and fosfomycin"
patients in treatment of RCDI and regularly encountered post-FMT re-infections with C. difficile following uncomplicated UTI treatment with all commonly used oral antibiotics, including quinolones, penicillins, cephalosporins, macrolides, sulfamethoxazole/trimethoprim, nitrofurantoin and fosfomycin
she had not had a UTI episode for over 3 months
regimen of methenamine hippurate and ascorbic acid
positive test for C. difficile
while on vancomycin
discharged after 3 days of treatment with amikacin
Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infection
Treatment of enterococcal infections - UpToDate
Treatment of enterococcal infections - UpToDate
Learn about the antimicrobial agents and approaches for different clinical syndromes caused by enterococci, such as urinary tract infections, bacteremia, endocarditis, and meningitis. Find out how to distinguish E. faecalis and E. faecium, and how to test for beta-lactamase and vancomycin
Treatment of enterococcal infections - UpToDate
The clinical heterogeneity of drug-induced myoclonus: an illustrated review
The clinical heterogeneity of drug-induced myoclonus: an illustrated review
A wide variety of drugs can cause myoclonus. To illustrate this, we first discuss two personally observed cases, one presenting with generalized, but facial-predominant, myoclonus that was induced by amantadine; and the other presenting with propriospinal ...
The clinical heterogeneity of drug-induced myoclonus: an illustrated review
Trospium | Side Effects, Dosage, Uses, and More
Trospium | Side Effects, Dosage, Uses, and More
Trospium oral tablet is a prescription medication that’s used to treat overactive bladder (OAB). It can help relieve symptoms such as urinary urgency, urinary frequency, and urine leaks. It’s available only as a generic drug. It doesn’t have a brand-name version. Learn about side effects, warnings, dosage, and more.
Trospium | Side Effects, Dosage, Uses, and More
Going Off Antidepressants - Harvard Health Publishing - Harvard Health
Going Off Antidepressants - Harvard Health Publishing - Harvard Health
People who have been taking antidepressants for some time may wish to stop taking them due to unpleasant side effects. This can be accomplished, but it is best to taper the dosage slowly and be awa...
bupropion (Wellbutrin) 21 hours 4.4 days
Going Off Antidepressants - Harvard Health Publishing - Harvard Health
Venlafaxine: Dosage, Mechanism/Onset of Action, Half-Life - Medicine.com
Venlafaxine: Dosage, Mechanism/Onset of Action, Half-Life - Medicine.com
Includes Venlafaxine indications, dosage/administration, pharmacology, mechanism/onset/duration of action, half-life, dosage forms, interactions, warnings, adverse reactions, off-label uses and more.
Urine (~87%;
Extended release: Venlafaxine: 6.3 ± 2.3 hour
10.7 ± 3.2 hours (extended-release
Venlafaxine: Dosage, Mechanism/Onset of Action, Half-Life - Medicine.com
Venlafaxine (Oral Route) Precautions - Mayo Clinic
Venlafaxine (Oral Route) Precautions - Mayo Clinic
may cause hyponatremia (low sodium
results of some tests may be affected by this medicine.
Venlafaxine may increase your risk for bleeding problems.
low amount of fluid in the body
trouble concentrating, memory problems, confusion, weakness, or feel unsteady when standing
Venlafaxine (Oral Route) Precautions - Mayo Clinic
Trospium: Dosage, Mechanism/Onset of Action, Half-Life - Medicine.com
Trospium: Dosage, Mechanism/Onset of Action, Half-Life - Medicine.com
Includes Trospium indications, dosage/administration, pharmacology, mechanism/onset/duration of action, half-life, dosage forms, interactions, warnings, adverse reactions, off-label uses and more.
MetFORMIN: May decrease the serum concentration of Trospium. Monitor therapy
Opioid Agonists: Anticholinergic Agents may enhance the adverse/toxic effect of Opioid Agonists. Specifically, the risk for constipation and urinary retention may be increased with this combination. Monitor therapy
Ophthalmic: Dry eye syndrome
confusion
hallucination
back pain,
CNS effects: May cause drowsiness, confusion, dizziness, hallucinations, and/or blurred vision, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (
morphine
Acetylcholinesterase Inhibitors: May diminish the therapeutic effect of Anticholinergic Agents. Anticholinergic Agents may diminish the therapeutic effect of Acetylcholinesterase Inhibitors.
antagonizes the effects of acetylcholine on muscarinic receptors in cholinergically innervated organs
Mirabegron: Anticholinergic Agents may enhance the adverse/toxic effect of Mirabegron
Potassium Citrate: Anticholinergic Agents may enhance the ulcerogenic effect of Potassium Citrate. Avoid combination
Trospium: Dosage, Mechanism/Onset of Action, Half-Life - Medicine.com
Alternative Choices to Oxybutynin: When, Why, and How Much?
Alternative Choices to Oxybutynin: When, Why, and How Much?
tolterodine (Detrol), and trospium (Sanctura)
tolterodine (Detrol), and trospium (Sanctura)
tolterodine and trospium are significantly less expensive, at about $2 per pill,
anticholinergic, trospium
does not readily cross the blood brain barrier
trospium
Alternative Choices to Oxybutynin: When, Why, and How Much?
These highlights do not include all the information needed to use Trospium Chloride Tablets safely and effectively. See full prescribing information for Trospium Chloride Tablets. Trospium Chloride Tablets, for oral use Initial U.S. Approval: 2004
These highlights do not include all the information needed to use Trospium Chloride Tablets safely and effectively. See full prescribing information for Trospium Chloride Tablets. Trospium Chloride Tablets, for oral use Initial U.S. Approval: 2004
creatinine clearance ranging from 30 to 80 mL/min
moderate and severe hepatic impairment.
increase in heart rate that correlates with increasing plasma concentrations.
500 mg metformin immediate release tablets twice daily reduced the steady-state systemic exposure of trospium by approximately 29% for mean
have an eye problem called "uncontrolled narrow-angle glaucoma"
These highlights do not include all the information needed to use Trospium Chloride Tablets safely and effectively. See full prescribing information for Trospium Chloride Tablets. Trospium Chloride Tablets, for oral use Initial U.S. Approval: 2004